Post by Audrey Ozols

Exactly! Preplaning is needed at the beginning of product development and throughout the process so the right information is collected for payer approval! CMS and FDA are always updating and changing rules so it’s important to stay engaged and reevaluate reimbursement strategy during the PDP process. #genomics #moleculartesting #CMS #FDA #davincihealthgroup